Osteoblast and monocyte responses to 444 ferritic stainless steel intended for a Magneto-Mechanically Actuated Fibrous Scaffold

Biomaterials

Volumn 32, Issue 29, 2011, Pages 6883-6892

  Malheiro, Vera N ^a   Spear, Rose L ^a   Brooks, Roger A ^b   Markaki, Athina E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Cell proliferation; Cell viability; Cytotoxicity; Monocyte; Osteoblast; Stainless steel

Indexed keywords

ALIZARIN RED; ALKALINE PHOSPHATASE ACTIVITY; BONE IMPLANT; BONE STRUCTURE; CELL VIABILITY; CELLULAR RESPONSE; CYTOTOXIC EFFECTS; FERRITIC STAINLESS STEEL; FIBROUS SCAFFOLDS; HUMAN CELLS; HUMAN MONOCYTES; IMPLANT DESIGN; IMPLANT DEVICES; IN-VIVO; INFLAMMATORY RESPONSE; INTERGRANULAR CORROSION; LACTATE DEHYDROGENASE ACTIVITIES; MONOCYTE; NECROSIS FACTORS; OSSEOINTEGRATION; OSTEOBLAST CELLS; OSTEOGENIC DIFFERENTIATION; PHALLOIDIN; SIMILAR DEGREE; TISSUE CULTURE PLASTICS;

ANIMAL CELL CULTURE; AUSTENITIC STAINLESS STEEL; BODY FLUIDS; BONE; CARBIDES; CELL PROLIFERATION; CORROSION RESISTANCE; CORROSION RESISTANT ALLOYS; CYTOTOXICITY; DESIGN; FERRITE; FERROMAGNETIC MATERIALS; MAMMALS; OSTEOBLASTS; PHOSPHATASES; SCAFFOLDS; SCANNING ELECTRON MICROSCOPY; TISSUE; TISSUE CULTURE;

FERRITIC STEEL;

ALIZARIN; ALKALINE PHOSPHATASE; FERROMAGNETIC MATERIAL; LACTATE DEHYDROGENASE; PHALLOIDIN; PLASTIC; STAINLESS STEEL; TISSUE SCAFFOLD; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ADHESION; CELL GROWTH; CELL PROLIFERATION; CELL TYPE; CELL VIABILITY; CORROSION; CYTOTOXICITY; FLUORESCENCE; HUMAN; HUMAN CELL; IMPLANT; INFLAMMATION; MONOCYTE; OSTEOBLAST; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

BIOCOMPATIBLE MATERIALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; HUMANS; INFLAMMATION; MATERIALS TESTING; MONOCYTES; OSSEOINTEGRATION; OSTEOBLASTS; PROSTHESES AND IMPLANTS; STAINLESS STEEL; SURFACE PROPERTIES; TISSUE SCAFFOLDS;

EID: 79960847027     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.06.002     Document Type: Article

References (55)

1. World biomedical metal market. Online 06/2010. Available from: http://www.acmite.com/pdf/SampleReadingBiomedicalMarket.pdf.
2. Asami K., Hashimoto K. Importance of initial surface film in the degradation of stainless steels by atmospheric exposure. Corros Sci 2003, 45:2263-2283.
3. Chiba A., Sakakura S., Kobayashi K., Kusayanagi K. Dissolution amounts of nickel, chromium and iron from SUS 304, 316 and 444 stainless steels in sodium chloride solutions. J Mater Sci 1997, 32:1995-2000.
4. Dowling N.J.E., Kim Y.H., Ahn S.K., Lee Y.D. Effect of alloying elements and residuals on corrosion resistance of type 444 stainless steel. Corrosion 1999, 55:187-199.
5. Oh K.T., Kim K.N., Lee M., Park Y.S. Corrosion wear of high molybdenum and nitrogen stainless steel for biomedical applications. J Electrochem Soc 2002, 149:B146-B153.
6. Oh K.T., Kim Y.S., Park Y.S., Kim K.N. Properties of super stainless steels for orthodontic applications. J Biomed Mater Res B Appl Biomater 2004, 69B:183-194.
7. Sun X.L., Ito A., Tateishi T., Hoshino A. Fretting corrosion resistance and fretting corrosion product cytocompatibility of ferritic stainless steel. J Biomed Mater Res 1997, 34:9-14.
8. Ciapetti G., Gonzelez-Carrasco J.L., Savarino L., Montealegre M.A., Pagani S., Baldini N. Quantitative assessment of the response of osteoblast- and macro-phage-like cells to particles of ni-free fe-base alloys. Biomaterials 2005, 26:849-859.
9. Flores M.S., Ciapetti G., Gonzelez-Carrasco J.L., Montealegre M.A., Multigner M., Pagani S., et al. Evaluation of magnetic behaviour and in vitro biocompatibility of ferritic PM2000 alloy. J Mater Sci Mater Med 2004, 15.
10. Herting G., Odnevall Wallinder I., Leygraf C. Metal release from various grades of stainless steel exposed to synthetic body fluids. Corros Sci 2007, 49:103-111.
11. Jansen J.A., von Recum A.F., van der Waerden J.P.C.M., de Groot K. Soft tissue response to different types of sintered metal fibre-web materials. Biomaterials 1992, 13:959-968.
12. Elster A.D., Burdette J.H. Questions & answers in magnetic resonance imaging 2001, Mosby, St. Louis. 2nd ed.
13. Tegawa Y. Dental magnetic attachment: toward third generation devices. IEEE Trans Biomed Eng 2008, 55:1185-1190.
14. Takada Y., Nakamura K., Kimura K., Okuno O. Corrosion behaviour of the stainless steel composing dental magnetic attachments. Int Congress Ser 2005, 1284:314-315.
15. Nakamura K., Takada Y., Yoda M., Kimura K., Okuno O. Galvanic corrosion of ferritic stainless steels used for dental magnetic attachments in contact with an iron-platinum magnet. Dent Mater J 2008, 27:203-210.
16. Guo C., Zhan D. Death patterns of the mouse fibroblast cell L929 induced by ferrite stainless steel in magnetic attachment. J Clin Rehabil Tissue Eng Res 2009, 13:4821-4824.
17. Markaki A.E., Clyne T.W. Magneto-mechanical stimulation of bone growth in a bonded array of ferromagnetic fibres. Biomaterials 2004, 25:4805-4815.
18. Markaki A.E., Clyne T.W. Magneto-mechanical actuation of bonded ferromagnetic fibre arrays. Acta Mater 2005, 53:877-889.
19. Frost H.M. Bone mass and the mechanostat - a proposal. Anat Rec 1987, 219:1-9.
20. Kerner J., Huiskes R., van Lenthe G.H., Weinans H., van Rietbergen B., Engh C.A., et al. Correlation between pre-operative periprosthetic bone density and post-operative bone loss in THA can be explained by strain-adaptive remodelling. J Biomech 1999, 32:695-703.
21. Lanyon L.E., Goodship A.E., Pye C.J., MacFie J.H. Mechanically adaptive bone remodelling. J Biomech 1982, 15:141-154.
22. Lee T.C., Staines A., Taylor D. Bone adaptation to load: microdamage, as a stimulus for bone remodelling. J Anat 2002, 201:437-446.
23. Markaki A.E., Clyne T.W. Mechanics of thin ultra-light stainless steel sandwich sheet material: part II - resistance to delamination. Acta Mater 2003, 51:1351-1357.
24. Tan J.C., Clyne T.W. Ferrous fibre network materials for noise reduction in gas turbine aeroengines, part II: thermomechanical stability. Adv Eng Mater 2008, 10:201-209.
25. Rubin C.T., Lanyon L.E. Regulation of bone mass by mechanical strain magnitude. Calcif Tissue Int 1985, 37:411-417.
26. ® cell proliferation assay. J Immunol Methods 2001, 254:85-98.
27. Lancaster MV, Fields RD. Antibiotic and cytotoxic drug susceptibility assays using resazurin and poising agents. US 5, 501, 9591996.
28. AlamarBlue™ Technical Datasheet 2002, AbD Serotec Ltd.
29. Katrak P., O'Connor B., Woodgate I. Rehabilitation after total femur replacement: a report of 2 cases. Arch Phys Med Rehabil 2003, 84:1080-1084.
30. Plant M.J., Underhill A., Cliffe J.E., Leach A.M., Jones P.W., Wynnjones C., et al. Rehabilitation and outcome after total shoulder replacement in rheumatic disease. J Orthop Rheumatol 1995, 8:12-19.
31. Rogers C.W., Firth E.C., McIlwraith C.W., Barneveld A., Goodship A.E., K C.E., et al. Evaluation of a new strategy to modulate skeletal development in thoroughbred performance horses by imposing track-based exercise during growth. Equine Vet J 2007, 40:111-118.
32. Seeherman H., Wozney J.M. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 2005, 16:329-345.
33. Wozney J.M. Overview of bone morphogenetic proteins. Spine 2002, 27:S2-S8.
34. Riccardi A., Grasso D., Danova M. Bisphosphonates in oncology: physiopathologic bases and clinical activity. Tumori 2003, 89:223-236.
35. Allgrove J. Use of bisphosphonates in children and adolescents. J Pediatr Endocrinol Metab 2002, 15:921-928.
36. Siris E.S., Pasquale M.K., Wang Y.T., Watts N.B. Estimating bisphosphonate use and fracture reduction among us women aged 45 years and older, 2001-2008. J Bone Miner Res 2011, 26:3-11.
37. Watts N.B., Diab D.L. Long-term use of bisphosphonates in osteoporosis. J Clin Endocrinol Metab 2010, 95:1555-1565.
38. Anselme K., Noel B., Hardouin P. Human osteoblast adhesion on titanium alloy, stainless steel, glass and plastic substrates with same surface topography. J Mater Sci Mater Med 1999, 10:815-819.
39. Keselowsky B.G., Collard D.M., Garcia A.J. Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation. Proc Natl Acad Sci U S A 2005, 102:5953-5957.
40. Brodbeck W.G., Nakayama Y., Matsuda T., Colton E., Ziats N.P., Anderson J.M. Surface chemistry dictates adherent monocyte/macrophage cytokine expression in vitro. Cytokine 2002, 18:311-319.
41. Shen M., Horbett T.A. The effects of surface chemistry and adsorbed proteins on monocyte/macrophage adhesion to chemically modified polystyrene surfaces. J Biomed Mater Res 2001, 57:336-345.
42. Soskolne W.A., Cohen S., Sennerby L., Wennerberg A., Shapira L. The effect of titanium surface roughness on the adhesion of monocytes and their secretion of TNF-alpha and PGE(2). Clin Oral Implants Res 2002, 13:86-93.
43. Boyan B.D., Lohmann C.H., Dean D.D., Sylvia V.L., Cochran D.L., Schwartz Z. Mechanisms involved in osteoblast response to implant surface morphology. Annu Rev Mater Res 2001, 31:357-371.
44. Martin J.Y., Schwartz Z., Hummert T.W., Schraub D.M., Simpson J., Lankford J., et al. Effect of titanium surface-roughness on proliferation, differentiation, and protein-synthesis of human osteoblast-like cells (Mg63). J Biomed Mater Res 1995, 29:389-401.
45. Traskine V., Protsenko P., Skvortsova Z., Volovitch P. Grain boundary wetting in polycrystals: wettability of structure elements and liquid phase connectivity (part I). Colloids Surf Physicochem Eng Aspects 2000, 166:261-268.
46. Tabrizian M., Faghihi S., Azari F., Li H., Bateni M.R., Szpunar J.A., et al. The significance of crystallographic texture of titanium alloy substrates on pre-osteoblast responses. Biomaterials 2006, 27:3532-3539.
47. Faghihi S., Azari F., Zhilyaev A.P., Szpunar J.A., Vali H., Tabrizian M. Cellular and molecular interactions between MC3T3-E1 pre-osteoblasts and nanostructured titanium produced by high-pressure torsion. Biomaterials 2007, 28:3887-3895.
48. Khang D., Lu J., Yao C., Haberstroh K.M., Webster T.J. The Role of Nanometer and Sub-Micron surface features on vascular and bone cell adhesion on titanium. Biomaterials 2008, 29:970-983.
49. Misra R.D.K., Thein-Han W.W., Pesacreta T.C., Hasenstein K.H., Somani M.C., Karjalainen L.P. Cellular response of preosteoblasts to nanograined/ultrafine-grained structures. Acta Biomater 2009, 5:1455-1467.
50. Park J.W., Kim Y.J., Park C.H., Lee D.H., Ko Y.G., Jang J.H., et al. Enhanced osteoblast response to an equal channel angular pressing-processed pure titanium substrate with microrough surface topography. Acta Biomater 2009, 5:3272-3280.
51. Schmidt C., Ignatius A.A., Claes L.E. Proliferation and differentiation parameters of human osteoblasts on titanium and steel surfaces. J Biomed Mater Res 2001, 54:209-215.
52. Tracey K.J., Cerami A. Tumor-necrosis-factor - a pleiotropic cytokine and therapeutic target. Annu Rev Med 1994, 45:491-503.
53. Buser D., Schenk R.K., Steinemann S., Fiorellini J.P., Fox C.H., Stich H. Influence of surface characteristics on bone integration of titanium implants - a histomorphometric study in miniature pigs. J Biomed Mater Res 1991, 25:889-902.
54. Zhao G., Schwartz Z., Wieland M., Rupp F., Geis-Gerstorfer J., Cochran D.L., et al. High surface energy enhances cell response to titanium substrate microstructure. J Biomed Mater Res Part A 2005, 74A:49-58.
55. Bailey L.O., Lipplatt S., Biancanello F.S., Ridder S.D., Washburn N.R. The quantification of cellular viability and inflammatory response to stainless steel alloys. Biomaterials 2005, 26:5296-5302.